"Peroxiredoxins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of ubiquitously-expressed peroxidases that play a role in the reduction of a broad spectrum of PEROXIDES like HYDROGEN PEROXIDE; LIPID PEROXIDES and peroxinitrite. They are found in a wide range of organisms, such as BACTERIA; PLANTS; and MAMMALS. The enzyme requires the presence of a thiol-containing intermediate such as THIOREDOXIN as a reducing cofactor.
- Alkylhydroperoxide Reductase
- Thioredoxin Peroxidase
- Protector Protein (Mixed-Function Oxidase Systems)
- Thiol-Specific Antioxidant Protein
- Thiol Specific Antioxidant Protein
- Alkyl Hydroperoxide Reductase
- Hydroperoxide Reductase, Alkyl
- Peroxiredoxin II
- Thioredoxin Peroxidase 1
- Thioredoxin-Dependent Peroxide Reductase 1
- Thioredoxin Dependent Peroxide Reductase 1
- Peroxiredoxin 2
- Peroxiredoxin I
- Thioredoxin Peroxidase 2
- Thioredoxin-Dependent Peroxide Reductase 2
- Thioredoxin Dependent Peroxide Reductase 2
- Peroxiredoxin 1
Below are MeSH descriptors whose meaning is more general than "Peroxiredoxins".
Below are MeSH descriptors whose meaning is more specific than "Peroxiredoxins".
This graph shows the total number of publications written about "Peroxiredoxins" by people in this website by year, and whether "Peroxiredoxins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Peroxiredoxins" by people in Profiles.
Jezierska-Drutel A, Attaran S, Hopkins BL, Skoko JJ, Rosenzweig SA, Neumann CA. The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases. BMC Cancer. 2019 Aug 16; 19(1):812.
He H, Guo F, Li Y, Saaoud F, Kimmis BD, Sandhu J, Fan M, Maulik D, Lessner S, Papasian CJ, Fan D, Jiang Z, Fu M. Adiporedoxin suppresses endothelial activation via inhibiting MAPK and NF-?B signaling. Sci Rep. 2016 12 12; 6:38975.
Zhang J, Grek C, Ye ZW, Manevich Y, Tew KD, Townsend DM. Pleiotropic functions of glutathione S-transferase P. Adv Cancer Res. 2014; 122:143-75.
Turner-Ivey B, Manevich Y, Schulte J, Kistner-Griffin E, Jezierska-Drutel A, Liu Y, Neumann CA. Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer. Oncogene. 2013 Nov 07; 32(45):5302-14.
Wolf BJ, Hill EG, Slate EH, Neumann CA, Kistner-Griffin E. LBoost: A boosting algorithm with application for epistasis discovery. PLoS One. 2012; 7(11):e47281.
Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, Jia Z, Lilly MB, De León M, Casiano CA. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate. 2011 May 15; 71(7):755-65.
Gharib SA, Nguyen E, Altemeier WA, Shaffer SA, Doneanu CE, Goodlett DR, Schnapp LM. Of mice and men: comparative proteomics of bronchoalveolar fluid. Eur Respir J. 2010 Jun; 35(6):1388-95.
Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle. 2009 Dec 15; 8(24):4072-8.
Cao J, Schulte J, Knight A, Leslie NR, Zagozdzon A, Bronson R, Manevich Y, Beeson C, Neumann CA. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 2009 May 20; 28(10):1505-17.
Ralat LA, Misquitta SA, Manevich Y, Fisher AB, Colman RF. Characterization of the complex of glutathione S-transferase pi and 1-cysteine peroxiredoxin. Arch Biochem Biophys. 2008 Jun 01; 474(1):109-18.